Antipsychotic Polypharmacy and Corrected QT Interval: A Systematic Review.
作者： Hiroyoshi Takeuchi , Takefumi Suzuki , Gary Remington , Hiroyuki Uchida
DOI: 10.1177/070674371506000503
关键词: Polypharmacy 、 Anesthesia 、 Increased risk 、 Medicine 、 Internal medicine 、 Cardiology 、 QT interval 、 Clinical Practice 、 Corrected qt 、 Antipsychotic 、 Cardiac sudden death
摘要: Objective:It remains unclear whether antipsychotic polypharmacy, a common clinical practice, is related to an increased risk of corrected time between start Q wave and end T (QTc) interv...
sagepub.com
elsevier.com
sci-hub.se 参考文章(42)
R.C. Guy, International Conference on Harmonisation Reference Module in Biomedical Sciences#R##N#Encyclopedia of Toxicology (Third Edition). pp. 1070- 1072 ,(2014) , 10.1016/B978-0-12-386454-3.00861-7
Irina Gurovich, Anitha Vempaty, Steven Lippmann, QTc prolongation: chlorpromazine and high-dosage olanzapine. The Canadian Journal of Psychiatry. ,vol. 48, pp. 348- 348 ,(2003) , 10.1177/070674370304800513
D. M. Taylor, L. Smith, S. H. Gee, J. Nielsen, Augmentation of clozapine with a second antipsychotic – a meta‐analysis Acta Psychiatrica Scandinavica. ,vol. 125, pp. 15- 24 ,(2012) , 10.1111/J.1600-0447.2011.01792.X
Roberto Leo, Cinzia Razzini, Giorgio Di Lorenzi, Manfredi Tesauro, Francesco Bianchi, Marco Zanasi, Alberto Siracusano, Francesco Romeo, Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol. The Journal of Clinical Psychiatry. ,vol. 69, pp. 327- 328 ,(2008) , 10.4088/JCP.V69N0221D
M Zink, A Kuwilsky, B Krumm, H Dressing, Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial. Journal of Psychopharmacology. ,vol. 23, pp. 305- 314 ,(2009) , 10.1177/0269881108089593
Marc Ziegenbein, Stefan Kropp, Heike E Kuenzel, Combination of clozapine and ziprasidone in treatment-resistant schizophrenia: an open clinical study. Clinical Neuropharmacology. ,vol. 28, pp. 220- 224 ,(2005) , 10.1097/01.WNF.0000183446.58529.30
S. Veerman, P. Schulte, M. Begemann, L. de Haan, Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis. Pharmacopsychiatry. ,vol. 47, pp. 231- 238 ,(2014) , 10.1055/S-0034-1385930
David C. Henderson, Xiaoduo Fan, Paul M. Copeland, Bikash Sharma, Christina P. Borba, Sharon I. Forstbauer, Kate Miley, Ryan Boxill, Oliver Freudenreich, Corrine Cather, Anne E. Evins, Donald C. Goff, Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia Human Psychopharmacology-clinical and Experimental. ,vol. 24, pp. 225- 232 ,(2009) , 10.1002/HUP.1012
Silvia G. Priori, Peter J. Schwartz, Carlo Napolitano, Raffaella Bloise, Elena Ronchetti, Massimiliano Grillo, Alessandro Vicentini, Carla Spazzolini, Janni Nastoli, Georgia Bottelli, Roberta Folli, Donata Cappelletti, Risk Stratification in the Long-QT Syndrome The New England Journal of Medicine. ,vol. 348, pp. 1866- 1874 ,(2003) , 10.1056/NEJMOA022147
Paul Mackin, Allan H. Young, QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study. The Journal of Clinical Psychiatry. ,vol. 66, pp. 1386- 1391 ,(2005) , 10.4088/JCP.V66N1107